Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q3 Loss, Tops Revenue Estimates

Rhythm Pharmaceuticals, Inc. (RYTM) came out with a quarterly loss of $0.73 per share versus the Zacks Consensus Estimate of a loss of$ 0.80. This compares to loss of $0.76 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 8.75%. A quarter ago, it was expected that this company would post a loss of$ 0.70 per share when it actually produced a loss of $0.55, delivering a surprise of 21.43%.Over the last four quarters, the company ...